Read more
15:50 · 6 May 2026

Nasdaq 100 has risen 25% from its March 31 low 📈 What’s next?

The US100 contract tracking the Nasdaq 100 index has rebounded by over 25% from its local low on March 31. A major driver behind this rally is the semiconductor sector, which in 2026 has once again become a key engine of optimism in the U.S. market. Looking at the US100 daily chart, the RSI is approaching 80, suggesting near-overbought conditions, while the scale of gains over the past 35 days has few precedents in the history of the U.S. equity market.

As a result, a pullback appears possible. In the short term, investors may look for key momentum support around 28,000 points (trendline) and 27,000 points (price action). On the other hand, if the upward move continues, a test of the 30,000 level could be a matter of weeks. This would likely require lower oil prices and increasing expectations of interest rate cuts following Kevin Warsh taking leadership at the Federal Reserve.

US100 (D1 interval)

Source: xStation5

Importantly, valuation multiples of companies within the index still appear subdued—mainly due to recent declines in the software sector and a strong earnings season. Combined price-to-earnings, price-to-sales, and price-to-book ratios remain at historically low levels.

Source: Bloomberg Finance L.P.

8 May 2026, 21:39

Daily Summary: Technology Drives Wall Street to Record Highs Despite Tensions in the Persian Gulf

8 May 2026, 19:55

🔴 Three markets to watch next week: EURUSD, CH50cash, OIL (08.05.2026)

8 May 2026, 18:33

US Open: Earnings season and strong NFP report drive Wall Street higher!

8 May 2026, 18:06

BREAKING: American Consumers Ease Inflation Fears, But Sentiment Stays Weak

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.